LORATADINE ORAL

LORATADINE ORAL was reported 49838 times

These side effects are most commonly reported by patients taking LORATADINE ORAL:

# Side effect Count
0 DRUG INEFFECTIVE 3709
1 FATIGUE 3380
2 NAUSEA 2816
3 DYSPNOEA 2542
4 HEADACHE 2518
5 DIARRHOEA 2471
6 OFF LABEL USE 2351
7 DIZZINESS 2169
8 PAIN 2047
9 RASH 1681
10 PRURITUS 1604
11 COUGH 1585
12 PNEUMONIA 1570
13 VOMITING 1540
14 ARTHRALGIA 1489
15 ASTHENIA 1471
16 ANXIETY 1378
17 SOMNOLENCE 1353
18 MALAISE 1352
19 PYREXIA 1283
20 FALL 1281
21 CHRONIC KIDNEY DISEASE 1210
22 INSOMNIA 1178
23 PAIN IN EXTREMITY 1144
24 DEATH 1096
25 CONDITION AGGRAVATED 1068
26 DEPRESSION 1065
27 BACK PAIN 1045
28 ACUTE KIDNEY INJURY 1022
29 CONSTIPATION 997
30 WEIGHT DECREASED 993
31 URTICARIA 948
32 PRODUCT DOSE OMISSION ISSUE 947
33 RENAL FAILURE 936
34 FEELING ABNORMAL 898
35 CHEST PAIN 889
36 DECREASED APPETITE 834
37 URINARY TRACT INFECTION 831
38 ABDOMINAL PAIN UPPER 825
39 HYPERTENSION 824
40 WEIGHT INCREASED 819
41 HYPERSENSITIVITY 813
42 COVID-19 801
43 MUSCLE SPASMS 796
44 ASTHMA 775
45 ABDOMINAL PAIN 766
46 GASTROOESOPHAGEAL REFLUX DISEASE 756
47 NASOPHARYNGITIS 743
48 PERIPHERAL SWELLING 714
49 PRODUCT USE IN UNAPPROVED INDICATION 708
50 ERYTHEMA 700
51 GAIT DISTURBANCE 685
52 ABDOMINAL DISCOMFORT 676
53 SINUSITIS 675
54 BLOOD PRESSURE INCREASED 673
55 HYPOTENSION 668
56 TREMOR 619
57 MYALGIA 617
58 PARAESTHESIA 612
59 CONFUSIONAL STATE 603
60 DRUG HYPERSENSITIVITY 599
61 PALPITATIONS 598
62 HYPOAESTHESIA 588
63 INCORRECT DOSE ADMINISTERED 584
64 CHEST DISCOMFORT 578
65 ANAEMIA 566
66 DRUG INTERACTION 564
67 VISION BLURRED 561
68 DEHYDRATION 557
69 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 549
70 INJECTION SITE PAIN 546
71 ALOPECIA 544
72 CHILLS 527
73 HEART RATE INCREASED 524
74 HYPERHIDROSIS 504
75 INFLUENZA 500
76 OROPHARYNGEAL PAIN 499
77 MEMORY IMPAIRMENT 495
78 OEDEMA PERIPHERAL 485
79 DRY MOUTH 453
80 ILLNESS 453
81 EXPIRED PRODUCT ADMINISTERED 451
82 WHITE BLOOD CELL COUNT DECREASED 450
83 LOSS OF CONSCIOUSNESS 446
84 SYNCOPE 443
85 DYSPEPSIA 437
86 SWELLING FACE 437
87 INFECTION 432
88 NEUROPATHY PERIPHERAL 431
89 PRODUCT USE ISSUE 428
90 FLUSHING 427
91 BRONCHITIS 424
92 MIGRAINE 420
93 FEBRILE NEUTROPENIA 417
94 ABDOMINAL DISTENSION 414
95 SEPSIS 413
96 RHINORRHOEA 409
97 WHEEZING 405
98 JOINT SWELLING 401
99 SEIZURE 396
100 EMOTIONAL DISTRESS 394
101 ATRIAL FIBRILLATION 393
102 EPISTAXIS 386
103 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 383
104 MUSCULAR WEAKNESS 382
105 UPPER RESPIRATORY TRACT INFECTION 380
106 HOSPITALISATION 378
107 BALANCE DISORDER 376
108 OVERDOSE 376
109 PLATELET COUNT DECREASED 376
110 DRY SKIN 374
111 END STAGE RENAL DISEASE 374
112 CONTUSION 370
113 PNEUMONIA ASPIRATION 367
114 VISUAL IMPAIRMENT 367
115 NASAL CONGESTION 366
116 SUICIDAL IDEATION 360
117 SWELLING 357
118 COMA 354
119 BLOOD GLUCOSE INCREASED 353
120 CEREBROVASCULAR ACCIDENT 348
121 HAEMOGLOBIN DECREASED 345
122 SLEEP DISORDER 345
123 HOT FLUSH 340
124 ARTHRITIS 337
125 TACHYCARDIA 331
126 ANAPHYLACTIC REACTION 330
127 AGITATION 329
128 NEUTROPENIA 323
129 PSORIASIS 320
130 OXYGEN SATURATION DECREASED 316
131 DYSPHAGIA 315
132 INFUSION RELATED REACTION 315
133 RENAL INJURY 313
134 TOXICITY TO VARIOUS AGENTS 312
135 DRUG DOSE OMISSION 310
136 PRODUCTIVE COUGH 306
137 GASTROINTESTINAL HAEMORRHAGE 300
138 MYOCARDIAL INFARCTION 300
139 PULMONARY EMBOLISM 298
140 FEELING HOT 297
141 LETHARGY 296
142 EXTRA DOSE ADMINISTERED 295
143 DIABETES MELLITUS 294
144 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 293
145 STRESS 293
146 ANGIOEDEMA 292
147 CELLULITIS 286
148 DYSPHONIA 283
149 MUSCULOSKELETAL STIFFNESS 281
150 SKIN EXFOLIATION 280
151 NO ADVERSE EVENT 279
152 HALLUCINATION 278
153 OSTEOPOROSIS 278
154 RASH PRURITIC 277
155 DYSGEUSIA 276
156 RESPIRATORY FAILURE 275
157 BONE PAIN 274
158 BURNING SENSATION 272
159 CARDIAC FAILURE CONGESTIVE 271
160 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 271
161 THROAT IRRITATION 267
162 NECK PAIN 266
163 DISEASE PROGRESSION 264
164 LIP SWELLING 263
165 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 263
166 OSTEOARTHRITIS 262
167 INFLUENZA LIKE ILLNESS 261
168 INJECTION SITE ERYTHEMA 260
169 AMNESIA 257
170 INTENTIONAL PRODUCT USE ISSUE 256
171 GASTROINTESTINAL DISORDER 251
172 EYE PAIN 248
173 THROMBOCYTOPENIA 248
174 STOMATITIS 243
175 UNEVALUABLE EVENT 243
176 DISTURBANCE IN ATTENTION 242
177 HAEMORRHAGE 242
178 PRODUCT QUALITY ISSUE 241
179 ALANINE AMINOTRANSFERASE INCREASED 239
180 BLOOD PRESSURE DECREASED 239
181 FLUID RETENTION 239
182 RENAL IMPAIRMENT 239
183 DISCOMFORT 238
184 DRUG INTOLERANCE 237
185 DEPRESSED MOOD 236
186 INTENTIONAL OVERDOSE 236
187 DERMATITIS ATOPIC 235
188 HEPATIC ENZYME INCREASED 234
189 THROMBOSIS 230
190 FLATULENCE 229
191 CARDIAC ARREST 225
192 MUSCULOSKELETAL PAIN 225
193 ANHEDONIA 224
194 BLISTER 223
195 DRY EYE 222
196 OEDEMA 220
197 DYSPNOEA EXERTIONAL 217
198 INJURY 217
199 TINNITUS 217
200 IRRITABILITY 215
201 HYPOKALAEMIA 213
202 THERAPEUTIC RESPONSE UNEXPECTED 213
203 RASH ERYTHEMATOUS 212
204 RHEUMATOID ARTHRITIS 211
205 VERTIGO 210
206 ARTHROPATHY 208
207 NEPHROLITHIASIS 208
208 SEASONAL ALLERGY 208
209 BLOOD CREATININE INCREASED 207
210 BLOOD CHOLESTEROL INCREASED 206
211 COMPLETED SUICIDE 205
212 DEEP VEIN THROMBOSIS 205
213 SURGERY 205
214 ACCIDENTAL OVERDOSE 201
215 HYPONATRAEMIA 201
216 NEPHROGENIC ANAEMIA 201
217 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 200
218 PLEURAL EFFUSION 200
219 SWOLLEN TONGUE 196
220 CATARACT 195
221 SUICIDE ATTEMPT 194
222 THERAPY INTERRUPTED 194
223 MOBILITY DECREASED 193
224 CARDIAC DISORDER 191
225 ECZEMA 191
226 HYPOXIA 191
227 UNDERDOSE 189
228 EYE IRRITATION 188
229 SPEECH DISORDER 188
230 ASPARTATE AMINOTRANSFERASE INCREASED 185
231 INTENTIONAL PRODUCT MISUSE 185
232 LACRIMATION INCREASED 185
233 NERVOUSNESS 185
234 ADVERSE DRUG REACTION 184
235 EAR INFECTION 182
236 AGGRESSION 181
237 INFUSION SITE PAIN 181
238 PRODUCT DOSE OMISSION 180
239 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 179
240 EYE SWELLING 178
241 DYSARTHRIA 177
242 GENERAL PHYSICAL HEALTH DETERIORATION 177
243 INJECTION SITE SWELLING 177
244 BLOOD POTASSIUM DECREASED 175
245 THERAPEUTIC RESPONSE DECREASED 174
246 PANIC ATTACK 173
247 SLEEP APNOEA SYNDROME 173
248 CARDIAC FAILURE 171
249 INFLAMMATION 171
250 MATERNAL EXPOSURE DURING PREGNANCY 171
251 CHOLELITHIASIS 170
252 HERPES ZOSTER 169
253 INJECTION SITE BRUISING 168
254 RASH MACULAR 168
255 EYE PRURITUS 167
256 MALIGNANT NEOPLASM PROGRESSION 167
257 SKIN DISCOLOURATION 167
258 DYSURIA 166
259 RENAL DISORDER 165
260 NIGHT SWEATS 164
261 POLLAKIURIA 164
262 TREATMENT NONCOMPLIANCE 163
263 DYSKINESIA 162
264 THROAT TIGHTNESS 162
265 ECONOMIC PROBLEM 160
266 THERAPEUTIC PRODUCT EFFECT DECREASED 160
267 INJECTION SITE PRURITUS 159
268 TYPE 2 DIABETES MELLITUS 158
269 DEVICE ISSUE 156
270 NEUTROPHIL COUNT DECREASED 155
271 THERAPY CESSATION 155
272 LIMB DISCOMFORT 154
273 NIGHTMARE 154
274 SNEEZING 153
275 BONE DENSITY DECREASED 151
276 COGNITIVE DISORDER 151
277 CRYING 151
278 DRUG EFFECT DECREASED 151
279 MULTIPLE SCLEROSIS RELAPSE 151
280 SINUS DISORDER 150
281 SKIN DISORDER 150
282 OCULAR HYPERAEMIA 149
283 LIMB INJURY 148
284 CONVULSION 147
285 LUNG DISORDER 147
286 FEELING COLD 146
287 HYPERSOMNIA 146
288 VIRAL INFECTION 146
289 LOWER RESPIRATORY TRACT INFECTION 145
290 RED BLOOD CELL COUNT DECREASED 144
291 MENTAL STATUS CHANGES 143
292 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 142
293 DYSSTASIA 142
294 BRADYCARDIA 141
295 RECTAL HAEMORRHAGE 140
296 SKIN BURNING SENSATION 140
297 TUBULOINTERSTITIAL NEPHRITIS 139
298 CYTOKINE RELEASE SYNDROME 138
299 PRODUCT SUBSTITUTION ISSUE 138
300 HYPOTHYROIDISM 137
301 MENTAL DISORDER 137
302 OSTEOPENIA 137
303 RESPIRATORY TRACT INFECTION 137
304 HAEMATOCHEZIA 135
305 DISEASE RECURRENCE 134
306 PULMONARY OEDEMA 134
307 ACNE 133
308 FUNGAL INFECTION 133
309 IMPAIRED QUALITY OF LIFE 133
310 PRODUCT DOSE OMISSION IN ERROR 133
311 ABNORMAL BEHAVIOUR 132
312 WHITE BLOOD CELL COUNT INCREASED 132
313 INJECTION SITE REACTION 131
314 SEPTIC SHOCK 131
315 ARRHYTHMIA 130
316 ILL-DEFINED DISORDER 127
317 PANCREATITIS 127
318 DIVERTICULITIS 126
319 HEART RATE IRREGULAR 126
320 PANCYTOPENIA 126
321 PNEUMONITIS 126
322 CYSTITIS 125
323 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 125
324 EAR PAIN 124
325 GASTRITIS 124
326 HEAD INJURY 124
327 REBOUND ACID HYPERSECRETION 124
328 SKIN LESION 124
329 ANGER 122
330 GASTRIC DISORDER 122
331 NEURALGIA 120
332 RESPIRATORY DISORDER 120
333 URINARY RETENTION 120
334 ABNORMAL DREAMS 119
335 MOOD SWINGS 119
336 PAIN IN JAW 119
337 RESTLESSNESS 119
338 ACCIDENTAL EXPOSURE TO PRODUCT 118
339 HEAD DISCOMFORT 118
340 ROAD TRAFFIC ACCIDENT 118
341 TRANSIENT ISCHAEMIC ATTACK 118
342 EXPOSURE DURING PREGNANCY 117
343 LYMPHADENOPATHY 117
344 THERAPY NON-RESPONDER 117
345 ACUTE MYOCARDIAL INFARCTION 116
346 HEPATIC STEATOSIS 116
347 CARDIO-RESPIRATORY ARREST 115
348 GAIT INABILITY 115
349 HAEMOPTYSIS 115
350 INFUSION SITE ERYTHEMA 115
351 LEUKOPENIA 115
352 ORAL PAIN 115
353 HYPERGLYCAEMIA 114
354 INTERVERTEBRAL DISC PROTRUSION 114
355 STAPHYLOCOCCAL INFECTION 114
356 URINARY INCONTINENCE 114
357 ACUTE RESPIRATORY FAILURE 113
358 FULL BLOOD COUNT DECREASED 113
359 MOVEMENT DISORDER 113
360 JOINT STIFFNESS 112
361 PRE-EXISTING CONDITION IMPROVED 112
362 PSORIATIC ARTHROPATHY 112
363 RESTLESS LEGS SYNDROME 112
364 ELECTROCARDIOGRAM QT PROLONGED 111
365 BLOOD GLUCOSE DECREASED 110
366 COLITIS 110
367 DISORIENTATION 110
368 INTESTINAL OBSTRUCTION 110
369 LIVER DISORDER 110
370 ADVERSE EVENT 109
371 EYE DISORDER 109
372 MULTIPLE SCLEROSIS 109
373 PRESYNCOPE 109
374 POOR QUALITY SLEEP 108
375 CORONARY ARTERY DISEASE 107
376 FOOT FRACTURE 107
377 MEDICATION ERROR 107
378 EMOTIONAL DISORDER 106
379 HYPOACUSIS 106
380 DEVICE MALFUNCTION 105
381 LOCALISED INFECTION 105
382 MOOD ALTERED 105
383 RENAL FAILURE ACUTE 105
384 TREATMENT FAILURE 105
385 BLOOD ALKALINE PHOSPHATASE INCREASED 104
386 GASTROENTERITIS VIRAL 104
387 HEART RATE DECREASED 104
388 HYPERPARATHYROIDISM SECONDARY 103
389 DRUG-INDUCED LIVER INJURY 102
390 LABORATORY TEST ABNORMAL 102
391 GALLBLADDER DISORDER 101
392 PRURITUS GENERALISED 101
393 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 101
394 FIBROMYALGIA 100
395 HYPERLIPIDAEMIA 100
396 INJECTION SITE HAEMORRHAGE 100
397 RETCHING 100
398 ANKLE FRACTURE 99
399 HAEMORRHOIDS 99
400 HIP FRACTURE 99
401 OBESITY 99
402 PHARYNGEAL SWELLING 99
403 PHOTOSENSITIVITY REACTION 99
404 HYPOGLYCAEMIA 98
405 PHOTOPHOBIA 98
406 PRODUCT ADMINISTRATION INTERRUPTED 98
407 DRUG EFFECT INCOMPLETE 97
408 INFUSION SITE SWELLING 97
409 PLASMA CELL MYELOMA 97
410 FEAR 96
411 HAEMATURIA 96
412 IMPAIRED GASTRIC EMPTYING 96
413 INTERNATIONAL NORMALISED RATIO INCREASED 96
414 MOUTH HAEMORRHAGE 96
415 RIB FRACTURE 96
416 PULMONARY HYPERTENSION 95
417 DEPRESSED LEVEL OF CONSCIOUSNESS 94
418 INJECTION SITE RASH 94
419 LIVER FUNCTION TEST ABNORMAL 94
420 BLOOD PRESSURE ABNORMAL 93
421 HAEMATOCRIT DECREASED 93
422 HYPERKALAEMIA 93
423 MUSCULOSKELETAL DISCOMFORT 93
424 SCIATICA 93
425 DELIRIUM 92
426 GOUT 92
427 HIATUS HERNIA 92
428 INTENTIONAL DOSE OMISSION 92
429 RASH GENERALISED 92
430 SINUS CONGESTION 92
431 VITAMIN D DEFICIENCY 92
432 BRAIN FOG 91
433 CHROMATURIA 91
434 FEELING JITTERY 91
435 HAEMATOMA 91
436 MIDDLE INSOMNIA 91
437 UNRESPONSIVE TO STIMULI 91
438 DIPLOPIA 90
439 HYPOPHAGIA 90
440 RESPIRATORY TRACT CONGESTION 90
441 SPINAL OSTEOARTHRITIS 90
442 THERAPEUTIC RESPONSE SHORTENED 90
443 CARPAL TUNNEL SYNDROME 89
444 FOETAL EXPOSURE DURING PREGNANCY 89
445 METABOLIC ACIDOSIS 89
446 MUSCLE TWITCHING 89
447 OBSTRUCTIVE AIRWAYS DISORDER 89
448 RASH MACULO-PAPULAR 89
449 BONE DISORDER 88
450 MULTIPLE ALLERGIES 88
451 MUSCLE TIGHTNESS 88
452 ORAL HERPES 88
453 WITHDRAWAL SYNDROME 88
454 BLOOD BILIRUBIN INCREASED 87
455 BREAST CANCER 87
456 FACE OEDEMA 87
457 BLOOD POTASSIUM INCREASED 86
458 CONJUNCTIVITIS 86
459 DRUG DEPENDENCE 86
460 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 86
461 JOINT INJURY 86
462 NEPHROPATHY 86
463 PSYCHOMOTOR HYPERACTIVITY 86
464 VAGINAL HAEMORRHAGE 86
465 CHOKING 85
466 DERMATITIS 85
467 LYMPHOCYTE COUNT DECREASED 85
468 STEVENS-JOHNSON SYNDROME 85
469 BLOOD SODIUM DECREASED 84
470 DIZZINESS POSTURAL 84
471 EPILEPSY 84
472 GENERALISED TONIC-CLONIC SEIZURE 84
473 PRODUCT TASTE ABNORMAL 84
474 RESPIRATORY DISTRESS 84
475 ABDOMINAL PAIN LOWER 83
476 DRUG WITHDRAWAL SYNDROME 83
477 EATING DISORDER 83
478 MOUTH ULCERATION 83
479 AGEUSIA 82
480 APHASIA 82
481 BLOOD PRESSURE FLUCTUATION 82
482 INTENTIONAL SELF-INJURY 82
483 INTERSTITIAL LUNG DISEASE 82
484 IRRITABLE BOWEL SYNDROME 82
485 ASCITES 81
486 HAEMATEMESIS 81
487 JOINT RANGE OF MOTION DECREASED 81
488 TOOTH DISORDER 81
489 ABORTION SPONTANEOUS 80
490 IMPAIRED HEALING 80
491 MUSCULOSKELETAL CHEST PAIN 80
492 SEDATION 80
493 BODY TEMPERATURE INCREASED 79
494 DERMATITIS CONTACT 79
495 ORAL DISCOMFORT 79
496 SMALL INTESTINAL OBSTRUCTION 79
497 ANGINA PECTORIS 78
498 BACK DISORDER 78
499 DRUG EFFECT LESS THAN EXPECTED 78
500 FEEDING DISORDER 78
501 NEOPLASM MALIGNANT 78
502 ORAL CANDIDIASIS 78
503 THINKING ABNORMAL 78
504 THIRST 78
505 BRONCHOSPASM 77
506 CROHN^S DISEASE 77
507 FAECES DISCOLOURED 77
508 GASTRIC ULCER 77
509 MUCOSAL INFLAMMATION 77
510 TOOTHACHE 77
511 TOXIC EPIDERMAL NECROLYSIS 77
512 WOUND 77
513 HYPOAESTHESIA ORAL 76
514 HYPOMAGNESAEMIA 76
515 INSURANCE ISSUE 76
516 MENTAL IMPAIRMENT 76
517 PHARYNGEAL OEDEMA 76
518 SKIN FISSURES 76
519 TASTE DISORDER 76
520 KIDNEY INFECTION 75
521 MULTIPLE FRACTURES 75
522 SKIN IRRITATION 75
523 UPPER LIMB FRACTURE 75
524 INTERVERTEBRAL DISC DEGENERATION 74
525 OROPHARYNGEAL DISCOMFORT 74
526 PARAESTHESIA ORAL 74
527 RENAL CYST 74
528 TENDONITIS 74
529 BACTERIAL INFECTION 73
530 BODY HEIGHT DECREASED 73
531 DEAFNESS 73
532 DRY THROAT 73
533 FEELING DRUNK 73
534 FEMUR FRACTURE 73
535 FLUID OVERLOAD 72
536 PSYCHOLOGICAL TRAUMA 72
537 SKIN HAEMORRHAGE 72
538 CLOSTRIDIUM DIFFICILE INFECTION 71
539 DRUG ERUPTION 71
540 GAMMA-GLUTAMYLTRANSFERASE INCREASED 71
541 HAIR COLOUR CHANGES 71
542 PALLOR 71
543 RESPIRATORY SYNCYTIAL VIRUS TEST POSITIVE 71
544 ROTATOR CUFF SYNDROME 71
545 SENSORY DISTURBANCE 71
546 VENTRICULAR TACHYCARDIA 71
547 BLINDNESS 70
548 PERICARDIAL EFFUSION 70
549 SECRETION DISCHARGE 70
550 PARANOIA 69
551 TENDERNESS 69
552 VISUAL ACUITY REDUCED 69
553 COLD SWEAT 68
554 DIABETES MELLITUS INADEQUATE CONTROL 68
555 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 68
556 HEPATITIS 68
557 LUNG NEOPLASM MALIGNANT 68
558 RASH PAPULAR 68
559 ACTIVITIES OF DAILY LIVING IMPAIRED 67
560 BLOOD PRESSURE SYSTOLIC INCREASED 67
561 PROCEDURAL PAIN 67
562 QUALITY OF LIFE DECREASED 67
563 HAIR TEXTURE ABNORMAL 66
564 HALLUCINATION, VISUAL 66
565 LIGAMENT SPRAIN 66
566 MULTIPLE ORGAN DYSFUNCTION SYNDROME 66
567 PULMONARY ARTERIAL HYPERTENSION 66
568 SCRATCH 66
569 SKIN ULCER 66
570 SYSTEMIC LUPUS ERYTHEMATOSUS 66
571 BLOOD UREA INCREASED 65
572 DEMENTIA 65
573 DIABETIC NEUROPATHY 65
574 EAR DISCOMFORT 65
575 HUMAN RHINOVIRUS TEST POSITIVE 65
576 IMMUNODEFICIENCY 65
577 NOCTURIA 65
578 RESPIRATORY ARREST 65
579 SCAR 65
580 SLUGGISHNESS 65
581 UPPER-AIRWAY COUGH SYNDROME 65
582 BIPOLAR DISORDER 64
583 BLOOD URINE PRESENT 64
584 CANDIDA INFECTION 64
585 RHINITIS ALLERGIC 64
586 SOMNAMBULISM 64
587 SPUTUM DISCOLOURED 64
588 TOOTH LOSS 64
589 CHOLECYSTITIS CHRONIC 63
590 COAGULOPATHY 63
591 DRUG ADMINISTRATION ERROR 63
592 HEPATIC FUNCTION ABNORMAL 63
593 HUNGER 63
594 LACTIC ACIDOSIS 63
595 MAST CELL ACTIVATION SYNDROME 63
596 PULMONARY MASS 63
597 RHINITIS 63
598 BLOOD COUNT ABNORMAL 62
599 JAUNDICE 62
600 PRODUCT STORAGE ERROR 62
601 PSYCHOTIC DISORDER 62
602 RENAL TUBULAR NECROSIS 62
603 ASTHMATIC CRISIS 61
604 C-REACTIVE PROTEIN INCREASED 61
605 FREQUENT BOWEL MOVEMENTS 61
606 GLAUCOMA 61
607 GLOSSODYNIA 61
608 INJECTION SITE MASS 61
609 LEUKOCYTOSIS 61
610 PHARMACEUTICAL PRODUCT COMPLAINT 61
611 ASPIRATION 60
612 BLOOD MAGNESIUM DECREASED 60
613 ERUCTATION 60
614 GLYCOSYLATED HAEMOGLOBIN INCREASED 60
615 INITIAL INSOMNIA 60
616 INJECTION SITE URTICARIA 60
617 MADAROSIS 60
618 PHARYNGITIS 60
619 TONGUE BITING 60
620 UPPER GASTROINTESTINAL HAEMORRHAGE 60
621 CHOLECYSTITIS 59
622 DEVICE DISLOCATION 59
623 HERNIA 59
624 PAIN OF SKIN 59
625 PHARYNGITIS STREPTOCOCCAL 59
626 POST PROCEDURAL COMPLICATION 59
627 PRESCRIBED OVERDOSE 59
628 SKIN INFECTION 59
629 TEMPERATURE INTOLERANCE 59
630 WRONG TECHNIQUE IN DRUG USAGE PROCESS 59
631 BLOOD CREATINE PHOSPHOKINASE INCREASED 58
632 CONTRAINDICATED PRODUCT ADMINISTERED 58
633 DEVICE RELATED INFECTION 58
634 INFUSION SITE PRURITUS 58
635 MASS 58
636 PANCREATITIS ACUTE 58
637 POST-TRAUMATIC STRESS DISORDER 58
638 RALES 58
639 TOOTH INFECTION 58
640 ATELECTASIS 57
641 COLITIS ULCERATIVE 57
642 COORDINATION ABNORMAL 57
643 DERMATITIS ALLERGIC 57
644 DIABETIC KETOACIDOSIS 57
645 ENCEPHALOPATHY 57
646 EYELID OEDEMA 57
647 FOOD ALLERGY 57
648 FOOT DEFORMITY 57
649 FULL BLOOD COUNT ABNORMAL 57
650 MICTURITION URGENCY 57
651 ORTHOSTATIC HYPOTENSION 57
652 VENTRICULAR FIBRILLATION 57
653 BLOOD TRIGLYCERIDES INCREASED 56
654 INCREASED APPETITE 56
655 LIVER FUNCTION TEST INCREASED 56
656 OBSESSIVE-COMPULSIVE DISORDER 56
657 PRODUCT PHYSICAL ISSUE 56
658 RENAL PAIN 56
659 SARS-COV-2 TEST POSITIVE 56
660 TARDIVE DYSKINESIA 56
661 ANAPHYLACTIC SHOCK 55
662 APHONIA 55
663 BLOOD IRON DECREASED 55
664 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 55
665 DISABILITY 55
666 FLANK PAIN 55
667 INFUSION SITE HAEMORRHAGE 55
668 PRODUCT AVAILABILITY ISSUE 55
669 RHABDOMYOLYSIS 55
670 SINUS TACHYCARDIA 55
671 TORSADE DE POINTES 55
672 CHRONIC SINUSITIS 54
673 ERECTILE DYSFUNCTION 54
674 GASTROENTERITIS 54
675 HYPOCALCAEMIA 54
676 INCORRECT PRODUCT ADMINISTRATION DURATION 54
677 IRON DEFICIENCY ANAEMIA 54
678 OSTEOMYELITIS 54
679 SPINAL FRACTURE 54
680 BLOOD CALCIUM DECREASED 53
681 CYSTIC FIBROSIS 53
682 DELUSION 53
683 DEVICE BREAKAGE 53
684 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 53
685 LOWER LIMB FRACTURE 53
686 NERVOUS SYSTEM DISORDER 53
687 PNEUMONIA HAEMOPHILUS 53
688 BLOOD GLUCOSE ABNORMAL 52
689 CHOLECYSTECTOMY 52
690 DECREASED ACTIVITY 52
691 DYSLIPIDAEMIA 52
692 GASTROINTESTINAL INFECTION 52
693 INJECTION SITE WARMTH 52
694 MANIA 52
695 MOUTH SWELLING 52
696 PELVIC PAIN 52
697 PULMONARY CONGESTION 52
698 SALIVARY HYPERSECRETION 52
699 SKIN SWELLING 52
700 WRIST FRACTURE 52
701 ABASIA 51
702 ANOSMIA 51
703 BASAL CELL CARCINOMA 51
704 BURSITIS 51
705 DENTAL CARIES 51
706 EXOSTOSIS 51
707 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 51
708 MAJOR DEPRESSION 51
709 NEOPLASM PROGRESSION 51
710 OVERWEIGHT 51
711 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 51
712 PRODUCT PRESCRIBING ERROR 51
713 PULMONARY THROMBOSIS 51
714 SPLENOMEGALY 51
715 BLOOD TEST ABNORMAL 50
716 CARDIOVASCULAR DISORDER 50
717 CHOLESTASIS 50
718 COVID-19 PNEUMONIA 50
719 EJECTION FRACTION DECREASED 50
720 EXPOSURE VIA SKIN CONTACT 50
721 HAIR DISORDER 50
722 KNEE ARTHROPLASTY 50
723 PERIPHERAL COLDNESS 50
724 VENTRICULAR EXTRASYSTOLES 50
725 VITREOUS FLOATERS 50
726 ACUTE HEPATIC FAILURE 49
727 CARDIOMEGALY 49
728 HOSPICE CARE 49
729 IMPAIRED WORK ABILITY 49
730 INFUSION SITE DISCHARGE 49
731 PAPULE 49
732 PERIORBITAL OEDEMA 49
733 PURPURA 49
734 SENSORY LOSS 49
735 SYNOVITIS 49
736 THYROID DISORDER 49
737 DEVICE LEAKAGE 48
738 ELECTROLYTE IMBALANCE 48
739 HEMIPARESIS 48
740 LIVER INJURY 48
741 NASAL DISCOMFORT 48
742 NASAL DRYNESS 48
743 OSTEONECROSIS 48
744 PARKINSON^S DISEASE 48
745 PRODUCT ADMINISTRATION ERROR 48
746 SKIN CANCER 48
747 SKIN LACERATION 48
748 TACHYPNOEA 48
749 WRONG DRUG ADMINISTERED 48
750 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 48
751 CEREBRAL INFARCTION 47
752 CORONARY ARTERY OCCLUSION 47
753 DECREASED IMMUNE RESPONSIVENESS 47
754 IMMUNE SYSTEM DISORDER 47
755 INCORRECT DRUG ADMINISTRATION DURATION 47
756 INJECTION SITE DISCOLOURATION 47
757 MUSCLE STRAIN 47
758 PLATELET COUNT INCREASED 47
759 SCAB 47
760 SENSITIVE SKIN 47
761 ULCER 47
762 DECUBITUS ULCER 46
763 EYE HAEMORRHAGE 46
764 FACIAL PAIN 46
765 FIBROSIS 46
766 HEPATIC FAILURE 46
767 LARYNGITIS 46
768 METASTASES TO BONE 46
769 WEIGHT FLUCTUATION 46
770 CARDIOMYOPATHY 45
771 DRUG ABUSE 45
772 DRUG PRESCRIBING ERROR 45
773 EUPHORIC MOOD 45
774 GRANULOCYTOPENIA 45
775 HALLUCINATION, AUDITORY 45
776 HEPATIC CIRRHOSIS 45
777 LEFT VENTRICULAR DYSFUNCTION 45
778 LOCAL SWELLING 45
779 NEEDLE ISSUE 45
780 PNEUMONIA BACTERIAL 45
781 PRODUCT PRESCRIBING ISSUE 45
782 RESPIRATORY SYNCYTIAL VIRUS INFECTION 45
783 RHINOVIRUS INFECTION 45
784 VIRAL TEST POSITIVE 45
785 ANAL INCONTINENCE 44
786 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 44
787 CONCUSSION 44
788 EYE DISCHARGE 44
789 IMPAIRED DRIVING ABILITY 44
790 LUNG INFECTION 44
791 MUSCLE ATROPHY 44
792 MUSCULOSKELETAL DISORDER 44
793 MYDRIASIS 44
794 NERVE COMPRESSION 44
795 SINUS HEADACHE 44
796 SKIN WARM 44
797 SWELLING OF EYELID 44
798 TOOTH FRACTURE 44
799 UROSEPSIS 44
800 VASCULITIS 44
801 VITAMIN D DECREASED 44
802 WALKING AID USER 44
803 ADRENAL INSUFFICIENCY 43
804 CEREBRAL HAEMORRHAGE 43
805 CYANOSIS 43
806 DYSTONIA 43
807 EYE INFECTION 43
808 EYE INFLAMMATION 43
809 HAND FRACTURE 43
810 HYPERVOLAEMIA 43
811 MITRAL VALVE INCOMPETENCE 43
812 NEUTROPHIL COUNT INCREASED 43
813 PNEUMOTHORAX 43
814 PRIAPISM 43
815 PRODUCT DISTRIBUTION ISSUE 43
816 RESPIRATORY RATE INCREASED 43
817 SPINAL DISORDER 43
818 TRANSFUSION 43
819 WRONG PRODUCT ADMINISTERED 43
820 BLOOD ALBUMIN DECREASED 42
821 GENERALISED OEDEMA 42
822 ILEUS 42
823 MENISCUS INJURY 42
824 OCULAR DISCOMFORT 42
825 SEROTONIN SYNDROME 42
826 TRICUSPID VALVE INCOMPETENCE 42
827 BACTERAEMIA 41
828 BLADDER DISORDER 41
829 ESSENTIAL HYPERTENSION 41
830 HYPOTHERMIA 41
831 INCREASED TENDENCY TO BRUISE 41
832 MALNUTRITION 41
833 OESOPHAGITIS 41
834 PARALYSIS 41
835 PSYCHIATRIC SYMPTOM 41
836 SNORING 41
837 SPINAL PAIN 41
838 THERAPY PARTIAL RESPONDER 41
839 AUTOIMMUNE HEPATITIS 40
840 BODY TEMPERATURE DECREASED 40
841 CYST 40
842 DRUG EXPOSURE DURING PREGNANCY 40
843 ELECTROCARDIOGRAM ABNORMAL 40
844 INCONTINENCE 40
845 PERITONITIS 40
846 PETECHIAE 40
847 TOOTH ABSCESS 40
848 TOOTH EXTRACTION 40
849 BOWEL MOVEMENT IRREGULARITY 39
850 CARDIAC MURMUR 39
851 EOSINOPHILIA 39
852 ERYTHEMA MULTIFORME 39
853 FINGER DEFORMITY 39
854 HYSTERECTOMY 39
855 INFLAMMATORY BOWEL DISEASE 39
856 INFUSION SITE EXTRAVASATION 39
857 OSTEONECROSIS OF JAW 39
858 SUPRAVENTRICULAR TACHYCARDIA 39
859 ABSCESS 38
860 ALTERED STATE OF CONSCIOUSNESS 38
861 BACK INJURY 38
862 BLINDNESS UNILATERAL 38
863 DEVICE OCCLUSION 38
864 DRUG DOSE OMISSION BY DEVICE 38
865 FRUSTRATION TOLERANCE DECREASED 38
866 HIP ARTHROPLASTY 38
867 INFUSION SITE INFECTION 38
868 PREGNANCY 38
869 PRODUCT USE COMPLAINT 38
870 PROTEINURIA 38
871 SCOLIOSIS 38
872 SHOCK 38
873 TRANSAMINASES INCREASED 38
874 ABNORMAL LOSS OF WEIGHT 37
875 AFFECTIVE DISORDER 37
876 ARTHROPOD BITE 37
877 BREAST PAIN 37
878 CEREBRAL DISORDER 37
879 CLOSTRIDIUM DIFFICILE COLITIS 37
880 DERMATITIS BULLOUS 37
881 DEVICE FAILURE 37
882 EOSINOPHIL COUNT INCREASED 37
883 GASTROINTESTINAL PAIN 37
884 PERSONALITY CHANGE 37
885 POLYP 37
886 ATAXIA 36
887 CARBUNCLE 36
888 DEFAECATION URGENCY 36
889 EXTRAPYRAMIDAL DISORDER 36
890 GRIP STRENGTH DECREASED 36
891 HAEMOGLOBIN INCREASED 36
892 HICCUPS 36
893 HYPOTHALAMO-PITUITARY DISORDER 36
894 INFUSION SITE REACTION 36
895 ISCHAEMIC STROKE 36
896 MYASTHENIA GRAVIS 36
897 NODULE 36
898 PSEUDOMONAS INFECTION 36
899 SUBDURAL HAEMATOMA 36
900 ARTERIOSCLEROSIS 35
901 ATRIOVENTRICULAR BLOCK 35
902 BRUXISM 35
903 DIVERTICULUM 35
904 INCORRECT ROUTE OF DRUG ADMINISTRATION 35
905 LOWER GASTROINTESTINAL HAEMORRHAGE 35
906 MENSTRUATION IRREGULAR 35
907 MONOCLONAL IMMUNOGLOBULIN PRESENT 35
908 PROTEIN TOTAL DECREASED 35
909 BONE LOSS 34
910 COMPLICATION ASSOCIATED WITH DEVICE 34
911 DEVICE DELIVERY SYSTEM ISSUE 34
912 FEELING OF DESPAIR 34
913 FRACTURE 34
914 GLUCOSE TOLERANCE IMPAIRED 34
915 JOINT EFFUSION 34
916 MACULAR DEGENERATION 34
917 MUSCLE SPASTICITY 34
918 PROSTATE CANCER 34
919 PULMONARY FIBROSIS 34
920 SQUAMOUS CELL CARCINOMA OF SKIN 34
921 TENSION HEADACHE 34
922 ACCIDENT 33
923 ANKYLOSING SPONDYLITIS 33
924 BLOOD THYROID STIMULATING HORMONE INCREASED 33
925 BONE MARROW FAILURE 33
926 DEVICE USE ERROR 33
927 DROOLING 33
928 ENERGY INCREASED 33
929 EXERCISE TOLERANCE DECREASED 33
930 GROIN PAIN 33
931 HYPERCHOLESTEROLAEMIA 33
932 LIP DRY 33
933 MELAENA 33
934 NERVE INJURY 33
935 ODYNOPHAGIA 33
936 PARANASAL SINUS DISCOMFORT 33
937 POISONING 33
938 POOR VENOUS ACCESS 33
939 PRESCRIBED UNDERDOSE 33
940 PROSTATIC SPECIFIC ANTIGEN INCREASED 33
941 THERMAL BURN 33
942 UTERINE LEIOMYOMA 33
943 BACTERIAL TEST POSITIVE 32
944 DRUG TOXICITY 32
945 ENURESIS 32
946 EYE MOVEMENT DISORDER 32
947 IMMUNOSUPPRESSION 32
948 JOINT DISLOCATION 32
949 PERIORBITAL SWELLING 32
950 PRODUCT ADHESION ISSUE 32
951 RIGHT VENTRICULAR FAILURE 32
952 SKIN ABRASION 32
953 SPINAL OPERATION 32
954 TUMOUR LYSIS SYNDROME 32
955 WOUND INFECTION 32
956 APPLICATION SITE ERYTHEMA 31
957 BEDRIDDEN 31
958 BUTTERFLY RASH 31
959 DEVICE DIFFICULT TO USE 31
960 DEVICE INFUSION ISSUE 31
961 DIVERTICULUM INTESTINAL 31
962 EMPHYSEMA 31
963 HEPATOMEGALY 31
964 HYPERCALCAEMIA 31
965 INCORRECT DRUG ADMINISTRATION RATE 31
966 LARYNGOSPASM 31
967 NEOPLASM 31
968 ORAL MUCOSAL BLISTERING 31
969 PRODUCT PREPARATION ERROR 31
970 SCREAMING 31
971 TEARFULNESS 31
972 VARICOSE VEIN 31
973 ASTHENOPIA 30
974 ATRIAL FLUTTER 30
975 CYSTIC FIBROSIS RESPIRATORY INFECTION SUPPRESSION 30
976 DRUG LEVEL INCREASED 30
977 DRUG SCREEN POSITIVE 30
978 DYSPNOEA AT REST 30
979 ESCHERICHIA INFECTION 30
980 HEPATOTOXICITY 30
981 HYPERVENTILATION 30
982 HYPOVOLAEMIA 30
983 INCOHERENT 30
984 INJECTION SITE HAEMATOMA 30
985 LACERATION 30
986 LIBIDO DECREASED 30
987 LYMPHOEDEMA 30
988 MALIGNANT MELANOMA 30
989 MENORRHAGIA 30
990 METASTASES TO LIVER 30
991 MYOCARDIAL ISCHAEMIA 30
992 MYOCLONUS 30
993 SENSATION OF FOREIGN BODY 30
994 SPINAL COMPRESSION FRACTURE 30
995 STRESS CARDIOMYOPATHY 30
996 VIRAL UPPER RESPIRATORY TRACT INFECTION 30
997 ABNORMAL FAECES 29
998 ANAL ABSCESS 29
999 AUTOIMMUNE DISORDER 29